[1]CurrentPatentAssignee:UNIVERSITYSYSTEMOFOHIO-US2008/33048,2008,A1Locationinpatent:Page/Pagecolumn2
Title: Real-time 2D separation by LC × differential ion mobility hyphenated to mass spectrometry.
Journal: Analytical and bioanalytical chemistry 20120301
Title: Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.
Journal: Bioorganic & medicinal chemistry letters 20101101
Title: Fendiline-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in human oral cancer cells.
Journal: Human & experimental toxicology 20090101
Title: Interaction of antagonists with calmodulin: insights from molecular dynamics simulations.
Journal: Journal of medicinal chemistry 20080612
Title: [Role of apoptosis in the kidney after reperfusion].
Journal: Orvosi hetilap 20080217
Title: 2'-hydroxy-fendiline analogues as potent relaxers of isolated arteries.
Journal: European journal of pharmacology 20070430
Title: Microsphere-based protease assays and screening application for lethal factor and factor Xa.
Journal: Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501
Title: Quantitative structure-pharmacokinetic relationships for drug clearance by using statistical learning methods.
Journal: Journal of molecular graphics & modelling 20060301
Title: Spectrofluorimetric determination of fendiline in tablets.
Journal: Die Pharmazie 20051001
Title: 3-Chloro,4-methoxyfendiline is a potent GABA(B) receptor potentiator in rat neocortical slices.
Journal: European journal of pharmacology 20050110
Title: Calcium sensing receptors as integrators of multiple metabolic signals.
Journal: Cell calcium 20040301
Title: Calcimimetic and calcilytic drugs: just for parathyroid cells?
Journal: Cell calcium 20040301
Title: Arylalkylamines are a novel class of positive allosteric modulators at GABA(B) receptors in rat neocortex.
Journal: European journal of pharmacology 20020906
Title: The anti-anginal drug fendiline elevates cytosolic Ca(2+) in rabbit corneal epithelial cells.
Journal: Life sciences 20020719
Title: Fendiline mobilizes intracellular Ca2+ in Chang liver cells.
Journal: Clinical and experimental pharmacology & physiology 20010901
Title: Fendiline, an anti-anginal drug, increases intracellular Ca2+ in PC3 human prostate cancer cells.
Journal: Cancer chemotherapy and pharmacology 20010701
Title: Effects of the antianginal drug fendiline on Ca2+ movement in hepatoma cells.
Journal: Human & experimental toxicology 20010701
Title: Determination of fendiline and gallopamil by capillary isotachophoresis.
Journal: Journal of chromatography. B, Biomedical sciences and applications 20010615
Title: Dual effect of the antianginal drug fendiline on bladder female transitional carcinoma cells: mobilization of intracellular CA2+ and induction of cell death.
Journal: Pharmacology 20010501
Title: Fendiline-Induced Ca2+ movement in A10 smooth muscle cells.
Journal: The Chinese journal of physiology 20010331
Title: The anti-anginal drug fendiline increases intracellular Ca(2+) levels in MG63 human osteosarcoma cells.
Journal: Toxicology letters 20010308
Title: A new potent calmodulin antagonist with arylalkylamine structure: crystallographic, spectroscopic and functional studies.
Journal: Journal of molecular biology 20000331
Title: Crystallization and preliminary diffraction analysis of Ca(2+)-calmodulin-drug and apocalmodulin-drug complexes.
Journal: Proteins 19970501
Title: [The relationship between anticonvulsant and anti-anxiety effects of calcium channel blockers].
Journal: Eksperimental'naia i klinicheskaia farmakologiia 19970101
Title: Inhibitors of calmodulin impair the constitutive but not the inducible nitric oxide synthase activity in the rat aorta.
Journal: The Journal of pharmacology and experimental therapeutics 19920501
Title: Effects of the calmodulin antagonists fendiline and calmidazolium on aggregation, secretion of ATP, and internal calcium in washed human platelets.
Journal: Naunyn-Schmiedeberg's archives of pharmacology 19910101
